Clinical Trial Update: East Asian Breast Cancer Genome Atlas and Recurrence Risk Prediction

View source ↗

Summary

A clinical trial sponsored by National Taiwan University Hospital evaluating East Asian breast cancer genomics to predict recurrence risk, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Breast Cancer | Status: RECRUITING